BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34598007)

  • 21. Diagnostic accuracy of technetium-99m-pertechnetate scintigraphy with lemon juice stimulation to evaluate Warthin's tumor.
    Murata Y; Yamada I; Umehara I; Okada N; Shibuya H
    J Nucl Med; 1998 Jan; 39(1):43-6. PubMed ID: 9443737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-parametric MR imaging using pseudo-continuous arterial-spin labeling and diffusion-weighted MR imaging in differentiating subtypes of parotid tumors.
    Razek AAKA
    Magn Reson Imaging; 2019 Nov; 63():55-59. PubMed ID: 31422165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of heavily T(2) weighted magnetic resonance images for the differential diagnosis of parotid tumours.
    Sakamoto M; Sasano T; Higano S; Takahashi S; Iikubo M; Kakehata S
    Dentomaxillofac Radiol; 2003 Sep; 32(5):295-9. PubMed ID: 14709603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interest of diffusion-weighted and gadolinium-enhanced dynamic MR sequences for the diagnosis of parotid gland tumors.
    Lechner Goyault J; Riehm S; Neuville A; Gentine A; Veillon F
    J Neuroradiol; 2011 May; 38(2):77-89. PubMed ID: 20542568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of T2-weighted-based radiomics model in distinguishing Warthin tumor from pleomorphic adenoma of the parotid.
    Hu Z; Guo J; Feng J; Huang Y; Xu H; Zhou Q
    Eur Radiol; 2023 Jun; 33(6):4453-4463. PubMed ID: 36502461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Value of manifestations of magnetic resonance imaging (MRI) in diagnosis of parotid tumors and their pathological bases].
    Yuan JP; Liang BL; Xie BK; Song ZC; Zhong JL
    Ai Zheng; 2003 May; 22(5):514-9. PubMed ID: 12753715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Performance of the magnetic resonance imaging in parotid gland tumor histopathology].
    Masmoudi M; Hasnaoui M; Guizani R; Lahmar R; Jerbi S; Mighri K
    Pan Afr Med J; 2021; 39():10. PubMed ID: 34178238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pleomorphic adenoma and adenolymphoma in ultrasonography.
    Zajkowski P; Jakubowski W; Białek EJ; Wysocki M; Osmólski A; Serafin-Król M
    Eur J Ultrasound; 2000 Sep; 12(1):23-9. PubMed ID: 10996767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential diagnosis of parotid gland tumours: which magnetic resonance findings should be taken in account?
    Tartaglione T; Botto A; Sciandra M; Gaudino S; Danieli L; Parrilla C; Paludetti G; Colosimo C
    Acta Otorhinolaryngol Ital; 2015 Oct; 35(5):314-20. PubMed ID: 26824912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gray scale and Doppler ultrasonography of the benign tumors of parotid gland (pleomorphic adenoma and Warthin's tumor). Pictorial essay.
    Fodor D; Pop S; Maniu A; Cosgaria M
    Med Ultrason; 2010 Sep; 12(3):238-44. PubMed ID: 21203603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and demographic data improve diagnostic accuracy of dynamic contrast-enhanced and diffusion-weighted MRI in differential diagnostics of parotid gland tumors.
    Mikaszewski B; Markiet K; Smugała A; Stodulski D; Szurowska E; Stankiewicz C
    Oral Oncol; 2020 Dec; 111():104932. PubMed ID: 32739792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiating parotid tumors by quantitative signal intensity evaluation on MR imaging.
    Matsusue E; Fujihara Y; Matsuda E; Tokuyasu Y; Nakamoto S; Nakamura K; Ogawa T
    Clin Imaging; 2017; 46():37-43. PubMed ID: 28704680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of dynamic MRI of Warthin's tumors arising as multiple lesions in the parotid glands.
    Hisatomi M; Asaumi J; Konouchi H; Yanagi Y; Matsuzaki H; Kishi K
    Oral Oncol; 2002 Jun; 38(4):369-72. PubMed ID: 12076701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on MRI images.
    Song LL; Chen SJ; Chen W; Shi Z; Wang XD; Song LN; Chen DS
    BMC Med Imaging; 2021 Mar; 21(1):54. PubMed ID: 33743615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI criteria for the diagnosis of pleomorphic adenoma: a validation study.
    Zaghi S; Hendizadeh L; Hung T; Farahvar S; Abemayor E; Sepahdari AR
    Am J Otolaryngol; 2014; 35(6):713-8. PubMed ID: 25128908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bilateral and multifocal Warthin's tumors of parotid glands: PET/CT imaging.
    Nguyen VX; Nguyen BD; Ram PC
    Clin Nucl Med; 2012 Feb; 37(2):175-7. PubMed ID: 22228345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of an MRI-based radiomics nomogram for distinguishing Warthin's tumour from pleomorphic adenomas of the parotid gland.
    Zheng YM; Chen J; Xu Q; Zhao WH; Wang XF; Yuan MG; Liu ZJ; Wu ZJ; Dong C
    Dentomaxillofac Radiol; 2021 Oct; 50(7):20210023. PubMed ID: 33950705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Capsule of parotid gland tumor: evaluation by 3.0 T magnetic resonance imaging using surface coils.
    Ishibashi M; Fujii S; Kawamoto K; Nishihara K; Matsusue E; Kodani K; Kaminou T; Ogawa T
    Acta Radiol; 2010 Dec; 51(10):1103-10. PubMed ID: 20883183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative dynamic contrast-enhanced MRI and readout segmentation of long variable echo-trains diffusion-weighted imaging in differentiating parotid gland tumors.
    Huang N; Xiao Z; Chen Y; She D; Guo W; Yang X; Chen Q; Cao D; Chen T
    Neuroradiology; 2021 Oct; 63(10):1709-1719. PubMed ID: 34241661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of parotid gland tumors using diffusion-relaxation correlation spectrum imaging: a preliminary study.
    Chen W; Geng D; Xu XQ; Hu WT; Dai YM; Wu FY; Zhu LN
    Clin Radiol; 2024 Jun; 79(6):e878-e884. PubMed ID: 38582630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.